Insider Transactions in Q2 2024 at Metagenomi, Inc. (MGX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2024
|
Jian Irish |
BUY
Grant, award, or other acquisition
|
Direct |
70,471
+19.08%
|
-
|
|
Apr 01
2024
|
Luis Borges Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
69,316
+50.0%
|
-
|
|
Apr 01
2024
|
Matthew Wein |
BUY
Grant, award, or other acquisition
|
Direct |
10,397
+50.0%
|
-
|
|
Apr 01
2024
|
Pamela Wapnick Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
69,316
+50.0%
|
-
|
|
Apr 01
2024
|
Sarah B. Noonberg Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,763
+36.53%
|
-
|
|
Apr 01
2024
|
Simon Harnest |
BUY
Grant, award, or other acquisition
|
Direct |
11,552
+8.61%
|
-
|
|
Apr 01
2024
|
Simren Delaney |
BUY
Grant, award, or other acquisition
|
Direct |
6,931
+6.87%
|
-
|
|
Apr 01
2024
|
Brian C. Thomas Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
118,992
+4.55%
|
-
|